Scholarly Research Exchange

Scholarly Research Exchange / 2008 / Article

Research Article | Open Access

Volume 2008 |Article ID 540872 | https://doi.org/10.3814/2008/540872

Guoliang Cui, Yuebo Zhang, Cindy Liu, Sheri Skinner, Ying Qin, "Pancreatic Cancer Suppression by Natural Polyphenols", Scholarly Research Exchange, vol. 2008, Article ID 540872, 6 pages, 2008. https://doi.org/10.3814/2008/540872

Pancreatic Cancer Suppression by Natural Polyphenols

Received10 Jun 2008
Accepted01 Aug 2008
Published26 Aug 2008

Abstract

Resveratrol and quercetin are polyphenols abundant in frequently consumed fruits, vegetables, and red wine. They have many biological activities, including antitumor, anti-inflammation, and antioxidation effects. This study evaluates the chemopreventive potential of resveratrol and quercetin against pancreatic cancer and investigates some of the underlying mechanisms. We report that resveratrol and quercetin suppress pancreatic tumor growth and that resveratrol extends life expectancy in a tumor bearing mouse model. Further, these two polyphenols inhibit growth of pancreatic cancer cell line, Panc02, in vitro. Results suggest that mechanisms may include induction of expression of caspase 3/8, causing DNA fragmentation, and arresting cells in G1 phase of the cell cycle. Cell invasion data reveals that both resveratrol and quercetin are able to decrease tumor cell invasion through an endothelial barrier. These data suggest that resveratrol and quercetin may be beneficial in pancreatic cancer treatment and metastasis prevention.

References

  1. A. Nakao, T. Fujii, H. Sugimoto et al., “Oncological problems in pancreatic cancer surgery,” World Journal of Gastroenterology, vol. 12, no. 28, pp. 4466–4472, 2006. View at: Google Scholar
  2. D. Li, K. Xie, R. Wolff, and J. L. Abbruzzese, “Pancreatic cancer,” The Lancet, vol. 363, no. 9414, pp. 1049–1057, 2004. View at: Publisher Site | Google Scholar
  3. G. Garcea, H. Doucas, W. P. Steward, A. R. Dennison, and D. P. Berry, “Hypoxia and angiogenesis in pancreatic cancer,” ANZ Journal of Surgery, vol. 76, no. 9, pp. 830–842, 2006. View at: Publisher Site | Google Scholar
  4. L. O. Dragsted, M. Strube, and T. Leth, “Dietary levels of plant phenols and other non-nutritive components: could they prevent cancer?,” European Journal of Cancer Prevention, vol. 6, no. 6, pp. 522–528, 1997. View at: Publisher Site | Google Scholar
  5. D. M. Goldberg, S. E. Hahn, and J. G. Parkes, “Beyond alcohol: beverage consumption and cardiovascular mortality,” Clinica Chimica Acta, vol. 237, no. 1-2, pp. 155–187, 1995. View at: Publisher Site | Google Scholar
  6. K. Subbaramaiah, W. J. Chung, P. Michaluart et al., “Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells,” The Journal of Biological Chemistry, vol. 273, no. 34, pp. 21875–21882, 1998. View at: Publisher Site | Google Scholar
  7. T. Kaneyuki, Y. Noda, M. G. Traber, A. Mori, and L. Packer, “Superoxide anion and hydroxyl radical scavenging activities of vegetable extracts measured using electron spin resonance,” IUBMB Life, vol. 47, no. 6, pp. 979–989, 1999. View at: Publisher Site | Google Scholar
  8. T. Wallerath, D. Poleo, H. Li, and U. Förstermann, “Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects,” Journal of the American College of Cardiology, vol. 41, no. 3, pp. 471–478, 2003. View at: Publisher Site | Google Scholar
  9. Z. Cao, J. Fang, C. Xia, X. Shi, and B.-H. Jiang, “trans-3,4,5-trihydroxystibene inhibits hypoxia-inducible factor 1α and vascular endothelial growth factor expression in human ovarian cancer cells,” Clinical Cancer Research, vol. 10, no. 15, pp. 5253–5263, 2004. View at: Publisher Site | Google Scholar
  10. J. A. Baur and D. A. Sinclair, “Therapeutic potential of resveratrol: the in vivo evidence,” Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 493–506, 2006. View at: Publisher Site | Google Scholar
  11. S. Fulda and K.-M. Debatin, “Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review,” Cancer Detection and Prevention, vol. 30, no. 3, pp. 217–223, 2006. View at: Publisher Site | Google Scholar
  12. D. Delmas, C. Rébé, S. Lacour et al., “Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells,” The Journal of Biological Chemistry, vol. 278, no. 42, pp. 41482–41490, 2003. View at: Publisher Site | Google Scholar
  13. M. Jang, L. Cai, G. O. Udeani et al., “Cancer chemopreventive activity of resveratrol, a natural product derived from grapes,” Science, vol. 275, no. 5297, pp. 218–220, 1997. View at: Publisher Site | Google Scholar
  14. L. Tessitore, A. Davit, I. Sarotto, and G. Caderni, “Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression,” Carcinogenesis, vol. 21, no. 8, pp. 1619–1622, 2000. View at: Google Scholar
  15. S. Banerjee, C. Bueso-Ramos, and B. B. Aggarwal, “Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9,” Cancer Research, vol. 62, no. 17, pp. 4945–4954, 2002. View at: Google Scholar
  16. D. W. Lamson and M. S. Brignall, “Antioxidants and cancer III: quercetin,” Alternative Medicine Review, vol. 5, no. 3, pp. 196–208, 2000. View at: Google Scholar
  17. M. Russo, R. Palumbo, I. Tedesco et al., “Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line,” FEBS Letters, vol. 462, no. 3, pp. 322–328, 1999. View at: Publisher Site | Google Scholar
  18. B. Csokay, N. Prajda, G. Weber, and E. Olah, “Molecular mechanisms in the antiproliferative action of quercetin,” Life Sciences, vol. 60, no. 24, pp. 2157–2163, 1997. View at: Publisher Site | Google Scholar
  19. M. Yoshida, M. Yamamoto, and T. Nikaido, “Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle,” Cancer Research, vol. 52, no. 23, pp. 6676–6681, 1992. View at: Google Scholar
  20. D. R. Ferry, A. Smith, J. Malkhandi et al., “Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition,” Clinical Cancer Research, vol. 2, no. 4, pp. 659–668, 1996. View at: Google Scholar
  21. N. Xing, Y. Chen, S. H. Mitchell, and C. Y. F. Young, “Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells,” Carcinogenesis, vol. 22, no. 3, pp. 409–414, 2001. View at: Publisher Site | Google Scholar
  22. E. Braganhol, L. L. Zamin, A. D. Canedo et al., “Antiproliferative effect of quercetin in the human U138MG glioma cell line,” Anti-Cancer Drugs, vol. 17, no. 6, pp. 663–671, 2006. View at: Publisher Site | Google Scholar
  23. Y. Wei, X. Zhao, Y. Kariya, H. Fukata, K. Teshigawara, and A. Uchida, “Induction of apoptosis by quercetin: involvement of heat shock protein,” Cancer Research, vol. 54, no. 18, pp. 4952–4957, 1994. View at: Google Scholar
  24. Z. Ma, T. Hung Nguyen, T. Hoa Huynh, P. Tien Do, and H. Huynh, “Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation,” Journal of Endocrinology, vol. 181, no. 3, pp. 493–507, 2004. View at: Publisher Site | Google Scholar
  25. I.-K. Wang, S.-Y. Lin-Shiau, and J.-K. Lin, “Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells,” European Journal of Cancer, vol. 35, no. 10, pp. 1517–1525, 1999. View at: Publisher Site | Google Scholar
  26. S. R. Datta, A. Brunet, and M. E. Greenberg, “Cellular survival: a play in three Akts,” Genes & Development, vol. 13, no. 22, pp. 2905–2927, 1999. View at: Publisher Site | Google Scholar
  27. D. Bernhard, I. Tinhofer, M. Tonko et al., “Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells,” Cell Death & Differentiation, vol. 7, no. 9, pp. 834–842, 2000. View at: Publisher Site | Google Scholar
  28. I. Murtaza, G. Marra, R. Schlapbach et al., “A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray,” Biotechnology and Applied Biochemistry, vol. 45, no. 1, pp. 29–36, 2006. View at: Publisher Site | Google Scholar
  29. M. R. Vijayababu, A. Arunkumar, P. Kanagaraj, and J. Arunakaran, “Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells,” Journal of Carcinogenesis, vol. 5, article 10, pp. 1–9, 2006. View at: Publisher Site | Google Scholar
  30. A. K. Joe, H. Liu, M. Suzui, M. E. Vural, D. Xiao, and I. B. Weinstein, “Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines,” Clinical Cancer Research, vol. 8, no. 3, pp. 893–903, 2002. View at: Google Scholar
  31. F. D. Ragione, V. Cucciolla, A. Borriello et al., “Resveratrol arrests the cell division cycle at S/G2 phase transition,” Biochemical and Biophysical Research Communications, vol. 250, no. 1, pp. 53–58, 1998. View at: Publisher Site | Google Scholar

Copyright © 2008 Guoliang Cui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views169
Downloads0
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.